Small molecule inhibition of proteasome and aggresome function induces synergistic anti-tumor activity in multiple myeloma.

被引：0
|
作者：
Hideshima, T
Bradner, JE
Wong, J
Chauhan, D
Richardson, PG
Schreiber, SL
Anderson, KC
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Harvard Univ, Med Sch, Boston, MA USA
[3] Harvard Univ, Broad Inst, Cambridge, MA USA
[4] MIT, Cambridge, MA USA
[5] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1570
引用
收藏
页码：450A / 451A
页数：2
相关论文
共 50 条
  • [1] Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma
    Hideshima, T
    Bradner, JE
    Wong, J
    Chauhan, D
    Richardson, P
    Schreiber, SL
    Anderson, KC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (24) : 8567 - 8572
  • [2] Dual inhibition of the Akt pathway by Rapamycin and Perifosine induces synergistic anti-tumor activity in multiple myeloma
    Cirstea, Diana
    Hideshima, Teru
    Ikeda, Hiroshi
    Pozzi, Samantha
    Vallet, Sonia
    Vaghela, Nileshwari
    Okawa, Yutaka
    Santo, Loredana
    Shweta, Chhetri
    Chhetri, Gaurav
    Patel, Chirayu
    Yan, Hua
    Kiziltepe, Tanyel
    Breitkreutz, Iris
    Anderson, Kenneth
    Raje, Noopur
    CANCER RESEARCH, 2008, 68 (09)
  • [3] Anti-Tumor Activity of Novel Small Molecule Wnt Signaling Inhibitor, CWP232291, In Multiple Myeloma.
    Cha, Joo Young
    Jung, Ji-Eun
    Lee, Kwan-Hoo
    Briaud, Isabelle
    Tenzin, Fnu
    Jung, Hee Kyung
    Pyon, Younghee
    Lee, Donghee
    Chung, Jae Uk
    Lee, Jong Heun
    Oh, Se-Woong
    Jung, Kyung Yun
    Pai, Jin Keon
    Emami, Kathy
    BLOOD, 2010, 116 (21) : 1252 - 1252
  • [4] In vivo anti-tumor activity of atiprimod on SCID models of multiple myeloma.
    Neri, P
    Tassone, P
    Shammas, MA
    Batchu, RB
    Blotta, S
    Samala, S
    Catley, L
    Hamasaki, M
    Hideshima, T
    Jacob, GS
    Picker, DH
    Venuta, S
    Anderson, KC
    Munshi, NC
    BLOOD, 2005, 106 (11) : 76A - 76A
  • [5] Anti-tumor activity of a novel immunosuppressant FTY720 in multiple myeloma.
    Yasui, H
    Hideshima, T
    Roccaro, AM
    Shiraishi, N
    Hamasaki, M
    Ishitsuka, K
    Kumar, S
    Raje, N
    Li, GL
    Tai, YT
    Podar, K
    Chauhan, D
    Anderson, KC
    BLOOD, 2004, 104 (11) : 941A - 942A
  • [6] Inhibition of fatty acid synthase induces anti-tumor effect in multiple myeloma
    Okawa, Y.
    Hideshima, T.
    Ikeda, H.
    Raje, N.
    Vallet, S.
    Kiziltepe, T.
    Enatsu, S.
    Pozzi, S.
    Richardson, P. G.
    Anderson, K. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Nifuroxazide inhibits STAT3 function. and shows potent anti-tumor activity against multiple myeloma.
    Nelson, Erik A.
    Hideshima, Teru
    Gashin, Laurie
    Walker, Sarah R.
    Lynch, Rebecca A.
    Chauhan, Dharminder
    Anderson, Kenneth C.
    Frank, David A.
    BLOOD, 2006, 108 (11) : 985A - 985A
  • [8] Anti-tumor activity of the proteasome inhibitor BSc2118 against human multiple myeloma
    Zang, Meirong
    Li, Zengjun
    Liu, Lanting
    Li, Fei
    Li, Xin
    Dai, Yun
    Li, Wei
    Kuckelkorn, Ulrike
    Doeppner, Thorsten R.
    Hermann, Dirk M.
    Zhou, Wen
    Qiu, Lugui
    Jin, Fengyan
    CANCER LETTERS, 2015, 366 (02) : 173 - 181
  • [9] BSC2118, a novel proteasome inhibitor with in vitro anti-tumor activity in multiple myeloma
    Sterz, J.
    Metzler, I. V.
    Kuckelkorn, U.
    Braun, H. A.
    Rotzer, S.
    Kaiser, M.
    Fleissner, C.
    Heider, U.
    Kloetzel, P. M.
    Sezer, O.
    Jakob, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 152 - 152
  • [10] Anti-tumor activity of pamidronate in human multiple myeloma
    Kondo, H
    Mori, A
    LEUKEMIA & LYMPHOMA, 2002, 43 (04) : 919 - 921
12345